Discover 2,396 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,396
Active & Responsive
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for
Coronavirus Disease (COVID-19)
Location: Annapolis MD, Columbia MD, Hampton VA, Newark NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06667700
Phase3, Recruiting
Active & Responsive
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
for
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Location: White Marsh MD, Norfolk VA, New York NY, The Bronx NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 12+
Code: NCT06338995
Phase3, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Bowie MD, Columbia MD, Camp Hill PA, Marlton NJ,
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Glen Burnie MD, Baltimore MD, Columbia MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase2, Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Glen Burnie MD, New York NY, Mentor OH, Providence RI,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase2, Recruiting
Active & Responsive
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
for
Healthy Volunteers, Hyperuricemia
Location: Baltimore MD
Sponsor: Novo Nordisk A/S
Sex: All
Age: 35 - 70+
Code: NCT06859073
Phase1, Recruiting
Active & Responsive
A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
for
Obesity, Overweight
Location: Baltimore MD, Glendale CA
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18 - 55
Code: NCT07566390
Phase1, Recruiting
Active & Responsive
A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
for
Overweight and Obesity
Location: Baltimore MD
Sponsor: Wave Life Sciences USA, Inc.
Sex: All
Age: 18 - 60
Code: NCT06842186
Phase1, Phase2, Recruiting
Active & Responsive
VTP-1000 in Adults With Celiac Disease
for
Celiac Disease
Location: Baltimore MD, Richmond VA, New York NY, Raleigh NC,
Sponsor: Barinthus Biotherapeutics
Sex: All
Age: 18 - 70
Code: NCT06310291
Early_phase1, Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Lanham MD, Clinton MD, Silver Spring MD, Takoma Park MD,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Recruiting
Active & Responsive
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
for
Posttraumatic Stress Disorder
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 21+
Code: NCT06989957
Phase1, Recruiting
Active & Responsive
Psilocybin Efficacy With or Without Pimavanserin Pretreatment
for
Mood (Psychological Function), Well Being, Mood, Healthy
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 21 - 65
Code: NCT07610135
Phase1, Phase2, Recruiting
Active & Responsive
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease